1. Home
  2. NEO vs TROX Comparison

NEO vs TROX Comparison

Compare NEO & TROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • TROX
  • Stock Information
  • Founded
  • NEO 2001
  • TROX 2018
  • Country
  • NEO United States
  • TROX United States
  • Employees
  • NEO N/A
  • TROX N/A
  • Industry
  • NEO Precision Instruments
  • TROX Major Chemicals
  • Sector
  • NEO Health Care
  • TROX Industrials
  • Exchange
  • NEO Nasdaq
  • TROX Nasdaq
  • Market Cap
  • NEO 965.2M
  • TROX 786.0M
  • IPO Year
  • NEO 1999
  • TROX 2005
  • Fundamental
  • Price
  • NEO $7.17
  • TROX $5.38
  • Analyst Decision
  • NEO Buy
  • TROX Buy
  • Analyst Count
  • NEO 9
  • TROX 8
  • Target Price
  • NEO $13.31
  • TROX $8.31
  • AVG Volume (30 Days)
  • NEO 1.6M
  • TROX 3.8M
  • Earning Date
  • NEO 04-29-2025
  • TROX 04-30-2025
  • Dividend Yield
  • NEO N/A
  • TROX 9.31%
  • EPS Growth
  • NEO N/A
  • TROX N/A
  • EPS
  • NEO N/A
  • TROX N/A
  • Revenue
  • NEO $672,361,000.00
  • TROX $3,038,000,000.00
  • Revenue This Year
  • NEO $13.95
  • TROX $2.80
  • Revenue Next Year
  • NEO $11.16
  • TROX $5.00
  • P/E Ratio
  • NEO N/A
  • TROX N/A
  • Revenue Growth
  • NEO 10.10
  • TROX 4.18
  • 52 Week Low
  • NEO $6.08
  • TROX $4.35
  • 52 Week High
  • NEO $19.12
  • TROX $20.70
  • Technical
  • Relative Strength Index (RSI)
  • NEO 37.02
  • TROX 50.10
  • Support Level
  • NEO $7.28
  • TROX $4.81
  • Resistance Level
  • NEO $7.63
  • TROX $5.76
  • Average True Range (ATR)
  • NEO 0.36
  • TROX 0.28
  • MACD
  • NEO -0.00
  • TROX 0.06
  • Stochastic Oscillator
  • NEO 9.26
  • TROX 57.92

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

Share on Social Networks: